Albert Gris

Albert Gris Oliver, PhD, is a postdoctoral researcher (R2A) at the Translational Research in Hepatic Oncology Group in IDIBAPS. He obtained his PhD in Biomedicine by the Universitat de Barcelona in 2017, studying novel drug combinations and defining biomarkers of response to chemotherapy and targeted therapy in cancer. After an international postdoctoral stage analyzing the role of innate immune cells in tumor progression, he is eager to identify biomarkers of response to immune-based therapies in the tumour microenvironment of liver cancer to improve therapy choice and resistance management.